Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma

Tumor Biology

Volumn 37, Issue 3, 2016, Pages 2961-2971

  Wang, Ling ^a   Cao, Na na ^a   Wang, Shan ^a   Man, Hong wei ^a   Li, Peng fei ^a   Shan, Bao en ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

B7 H3; B7 H4; Coinhibitory molecules; Esophageal squamous cell carcinoma

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; B7-H3 PROTEIN; PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1; 4-NITROQUINOLONE-1-OXIDE; B7 ANTIGEN; CD276 PROTEIN, HUMAN; QUINOLONE DERIVATIVE; VTCN1 PROTEIN, HUMAN;

ADULT; ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELLS BY BODY ANATOMY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; IMMUNOSURVEILLANCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; AGED; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; ESOPHAGUS TUMOR; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

4-NITROQUINOLINE-1-OXIDE; ADULT; AGED; ANIMALS; B7 ANTIGENS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED C57BL; MIDDLE AGED; QUINOLONES; V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1;

EID: 84944672242     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4132-5     Document Type: Article

References (43)

1. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381:400–12.
2. Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol WJG. 2013;19:5598–606.
3. Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J, et al. Epidemiology of esophageal cancer in japan and china. J Epidemiol / Japan Epidemiol Assoc. 2013;23:233–42.
4. Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L, He J: Report of incidence and mortality in china cancer registries, 2009. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 2013;25:10–21.
5. Esophageal cancer: Epidemiology, pathogenesis and prevention. Nature clinical practice Gastroenterology & hepatology 2008;5:517–526.
6. Napier KJ, Scheerer M, Misra S. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointestinal Oncol. 2014;6:112–20.
7. Wang L, Kang FB, Shan BE. B7-h3-mediated tumor immunology: friend or foe? Int J Cancer J Int Cancer. 2014;134:2764–71.
8. Yu N, Li X, Zheng S, Li X. B7-H4’s role “beyond the tumor”. Inflammation. 2013;36:941–7.
9. Sun M, Richards S, Prasad DV, Mai XM, Rudensky A, Dong C. Characterization of mouse and human B7-H3 genes. J Immunol. 2002;168:6294–7.
10. Suh WK, Gajewska BU, Okada H, Gronski MA, Bertram EM, Dawicki W, et al. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat Immunol. 2003;4:899–906.
11. Zang X, Thompson RH, Al-Ahmadie HA, Serio AM, Reuter VE, Eastham JA, et al. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci U S A. 2007;104:19458–63.
12. Wang L, Zhang Q, Chen W, Shan B, Ding Y, Zhang G, et al. B7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis. PLoS ONE. 2013;8, e70689.
13. Kang FB, Wang L, Jia HC, Li D, Li HJ, Zhang YG, et al. B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway. Cancer Cell Int. 2015;15:45.
14. Kang FB, Wang L, Li D, Zhang YG, Sun DX. Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression. Oncol Rep. 2015;33:274–82.
15. Prasad DV, Richards S, Mai XM, Dong C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity. 2003;18:863–73.
16. Salceda S, Tang T, Kmet M, Munteanu A, Ghosh M, Macina R, et al. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res. 2005;306:128–41.
17. Sica GL, Choi IH, Zhu G, Tamada K, Wang SD, Tamura H, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity. 2003;18:849–61.
18. Kryczek I, Wei S, Zhu G, Myers L, Mottram P, Cheng P, et al. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res. 2007;67:8900–5.
19. Chen LJ, Sun J, Wu HY, Zhou SM, Tan Y, Tan M, et al. B7-H4 expression associates with cancer progression and predicts patient’s survival in human esophageal squamous cell carcinoma. Cancer Immunol, Immunotherapy CII. 2011;60:1047–55.
20. Wang L, Kang F, Li J, Zhang J, Shan B. Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line. Cancer Cell Int. 2013;13:14.
21. Quandt D, Fiedler E, Boettcher D, Marsch W, Seliger B. B7-H4 expression in human melanoma: its association with patients’ survival and antitumor immune response. Clin Cancer Res Off J Am Assoc Cancer Res. 2011;17:3100–11.
22. Wang J, Jia Y, Wang N, Zhang X, Tan B, Zhang G, et al. The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma. J Transl Med. 2014;12:7.
23. Nishikawa H, Sakaguchi S. Regulatory T cells in cancer immunotherapy. Curr Opin Immunol. 2014;27:1–7.
24. Whiteside TL. Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression? Cancer Immunol, Immunotherapy CII. 2014;63:67–72.
25. Ostuni R, Kratochvill F, Murray PJ, Natoli G. Macrophages and cancer: from mechanisms to therapeutic implications. Trends Immunol. 2015;36:229–39.
26. Laoui D, Van Overmeire E, De Baetselier P, Van Ginderachter JA, Raes G. Functional relationship between tumor-associated macrophages and macrophage colony-stimulating factor as contributors to cancer progression. Front Immunol. 2014;5:489.
27. Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, et al. Tumor-associated macrophages and survival in classic Hodgkin’s lymphoma. N Engl J Med. 2010;362:875–85.
28. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141:39–51.
29. Tseng SH, Yang CC, Yu EH, Chang C, Lee YS, Liu CJ, et al. K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression. Int J Cancer J Int Cancer. 2015;136:1263–75.
30. Wilkey JF, Buchberger G, Saucier K, Patel SM, Eisenberg E, Nakagawa H, et al. Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium. Mol Carcinog. 2009;48:853–61.
31. Mao Y, Li W, Chen K, Xie Y, Liu Q, Yao M, et al. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer. Oncotarget. 2015;6:3452–61.
32. Li M, Zhang G, Zhang X, Lv G, Wei X, Yuan H, et al. Overexpression of B7-H3 in CD14+ monocytes is associated with renal cell carcinoma progression. Med Oncol. 2014;31:349.
33. Ingebrigtsen VA, Boye K, Nesland JM, Nesbakken A, Flatmark K, Fodstad O. B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome. BMC Cancer. 2014;14:602.
34. Hu Y, Lv X, Wu Y, Xu J, Wang L, Chen W, et al. Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia. Hematology. 2015;20:187–95.
35. Lin DC, Du XL, Wang MR. Protein alterations in ESCC and clinical implications: a review. Diseases Esophagus Off J Int Soc Diseases Esophagus / ISDE. 2009;22:9–20.
36. Sakai NS, Samia-Aly E, Barbera M, Fitzgerald RC. A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Semin Cancer Biol. 2013;23:512–21.
37. Wang G, Sun Y, Ji C, He Y, Hu C, Jiang F, et al. Correlation between the CD4 + CD25high regulatory T cells and the outcome of chemotherapy in advanced esophageal carcinoma. Hepato-Gastroenterology. 2013;60:704–8.
38. Nabeki B, Ishigami S, Uchikado Y, Sasaki K, Kita Y, Okumura H, et al. Interleukin-32 expression and Treg infiltration in esophageal squamous cell carcinoma. Anticancer Res. 2015;35:2941–7.
39. Kristensen NN, Schmidt EG, Rasmussen S, Balk-Moller E, Claesson MH. B7-H4-Ig treatment of normal mice changes lymphocyte homeostasis and increases the potential of regulatory T cells. Immunopharmacol Immunotoxicol. 2013;35:505–13.
40. Josephs DH, Bax HJ, Karagiannis SN. Tumour-associated macrophage polarisation and re-education with immunotherapy. Front Biosci. 2015;7:293–308.
41. Chanmee T, Ontong P, Konno K, Itano N. Tumor-associated macrophages as major players in the tumor microenvironment. Cancers. 2014;6:1670–90.
42. Medrek C, Ponten F, Jirstrom K, Leandersson K. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer. 2012;12:306.
43. Peng HX, Wu WQ, Yang DM, Jing R, Li J, Zhou FL, et al. Role of B7-H4 siRNA in proliferation, migration, and invasion of LOVO colorectal carcinoma cell line. BioMed Res Int. 2015;2015:326981.